Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?

Cleve Clin J Med. 2021 Apr 1;88(4):213-215. doi: 10.3949/ccjm.88a.20194.

Authors

Achintya D Singh¹, Agrima Mian², James K Stoller³

Affiliations

¹ Resident, Department of Internal Medicine, Cleveland Clinic, Cleveland, OH singha8@ccf.org.
² Resident, Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
³ Chairman, Education Institute; Staff, Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

PMID: 33795244
DOI: 10.3949/ccjm.88a.20194

No abstract available

MeSH terms

COVID-19* / diagnosis
COVID-19* / physiopathology
COVID-19* / therapy
Duration of Therapy
Humans
Male
Middle Aged
Prednisone / administration & dosage*
Pulmonary Disease, Chronic Obstructive* / diagnosis
Pulmonary Disease, Chronic Obstructive* / drug therapy
Pulmonary Disease, Chronic Obstructive* / physiopathology
Remote Consultation / methods*
SARS-CoV-2
Steroids / administration & dosage
Symptom Assessment / methods*
Symptom Flare Up*
Treatment Outcome

Substances

Steroids
Prednisone